This claim is based on the results of clinical trials that evaluated the effects of the weight loss medications offered through the Ro Body Program, including Zepbound (tirzepatide) and Wegovy (semaglutide)
Common side effects observed in monotherapy trials, similar to other GLP-1 receptor agonists, include gastrointestinal symptoms such as nausea, diarrhea, and vomiting, with most adverse events being mild to moderate in severity
Clinical guidance generally advises avoiding this class in patients with a pancreatitis history unless there's no reasonable alternative
JUNE 24, 2026 The most anticipated weight-loss drug in the world has not been approved anywhere
4 nutrients that increase natural GLP-1 production While no food can replicate the powerful effects of GLP-1 medications, certain nutrients can encourage your body to produce more of this helpful hormone
Fluid retention and oedema a known adverse effect of tesamorelin, which could be compounded by broader metabolic shifts